Product image of Meropenem Sun (Meropenem Anhydrous) supplied by GNH India

Meropenem Sun

Active Ingredient:
Meropenem Anhydrous
Origin:
EU

Meropenem Sun (Meropenem Anhydrous)

Meropenem, the active ingredient in Meropenem Sun, is a carbapenem antibiotic presented as an injectable formulation for intravenous use. It provides broad‑spectrum antibacterial activity against Gram‑negative and Gram‑positive pathogens and is employed in severe hospital‑acquired infections.

GNH India supplies Meropenem Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and delivering the product across multiple continents.

Manufacturer / TM Owner

Sun Pharmaceutical Industries Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meropenem is used to treat serious bacterial infections that affect the abdominal, urinary, respiratory and central nervous systems.
  • Complicated intra‑abdominal infections: eliminates causative bacteria and improves clinical outcomes.
  • Complicated urinary tract infections: eradicates resistant uropathogens and resolves infection.
  • Nosocomial pneumonia: provides rapid bacterial clearance in hospital‑acquired lung infections.
  • Septicemia: achieves systemic bacterial control and reduces mortality risk.
  • Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis effectively.

How It Works

  • Meropenem binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its high affinity for a broad range of PBPs gives it activity against many Gram‑negative, Gram‑positive and anaerobic organisms, including many resistant strains.

Side Effects

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects

  • Nausea or vomiting
  • Diarrhea, including mild C. difficile‑associated colitis
  • Headache
  • Infusion site erythema or phlebitis

Serious or Rare Side Effects

  • Seizures, especially in patients with renal impairment
  • Anaphylactic or severe hypersensitivity reactions
  • Severe C. difficile‑associated colitis
  • Neutropenia or thrombocytopenia
  • Elevated liver enzymes indicating hepatic injury

Precautions & Warnings

When prescribing Meropenem, clinicians should consider several safety and handling precautions.

  • Renal impairment: adjust dose based on creatinine clearance.
  • Hepatic dysfunction: monitor liver function tests during therapy.
  • History of seizures: use with caution as the drug may lower seizure threshold.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Drug interactions: review concomitant medications for potential interactions.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem can interact with other medicines, affecting efficacy or toxicity.

Major Interactions (Avoid)

  • Valproic acid: reduced serum levels may precipitate seizure breakthrough.
  • Probenecid: increased meropenem concentrations can raise toxicity risk.
  • Cytotoxic agents (e.g., cyclophosphamide): additive nephrotoxicity may occur.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: monitor renal function and electrolytes.
  • Aminoglycosides: watch for combined nephrotoxic effects.
  • Anticoagulants (warfarin): monitor INR for potential alteration of anticoagulant effect.

Frequently Asked Questions

Meropenem Sun is an intravenous carbapenem antibiotic indicated for the treatment of severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired (nosocomial) pneumonia, septicemia and bacterial meningitis.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the final cross‑linking step of peptidoglycan formation. This leads to weakened cell walls, osmotic instability and bacterial lysis, providing broad‑spectrum activity against many resistant Gram‑negative and Gram‑positive organisms.

The prescribed dose of Meropenem Sun is determined by the treating physician based on the type and severity of infection, patient weight, renal and hepatic function, and local antimicrobial susceptibility patterns. No fixed regimen is provided here.

Safety data for Meropenem Sun in pregnancy and lactation are limited. It is classified as pregnancy category unknown, and use is recommended only when the potential benefit justifies the potential risk to the fetus or infant.

To order Meropenem Sun, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Meropenem offers a broad spectrum of activity similar to other carbapenems like imipenem and ertapenem, but it is more stable against many beta‑lactamases and provides reliable coverage for both Gram‑negative and Gram‑positive pathogens, making it a preferred option for multidrug‑resistant infections.

Meropenem Sun should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Once reconstituted, it should be used within the time frame specified in the product labeling and kept under the same temperature conditions.

Meropenem Sun is administered by intravenous infusion. The infusion rate and duration are determined by the prescribing clinician, typically over 15‑30 minutes, and may be adjusted based on patient tolerance and clinical response.

Serious risks include the potential for seizures, especially in patients with renal impairment, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis, which can be life‑threatening if not promptly recognized and treated.

Meropenem Sun should be avoided in patients with a known hypersensitivity to meropenem, other carbapenems, or any beta‑lactam antibiotics. Caution is also advised for patients with a history of seizures, severe renal impairment, or those receiving interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT